免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

虎眼CTO-Crossing 穿刺導管

K 號:K201330 · 2020-09-10

申請人Avinger, Inc.
決定日期2020-09-10
產品代碼PDU
諮詢委員會履歷
決定相當於

器材摘要

Tigereye CTO-Crossing Catheter is the device name listed in this FDA 510(k) record. The listed applicant is Avinger, Inc.. It received FDA 510(k) clearance on 2020-09-10 under 510(k) number K201330. The device is classified under product code PDU. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Tigereye CTO-Crossing Catheter?

Tigereye CTO-Crossing Catheter is a medical device that received FDA 510(k) clearance on 2020-09-10. The listed applicant is Avinger, Inc.. The 510(k) number is K201330.

When did Tigereye CTO-Crossing Catheter receive FDA 510(k) clearance?

Tigereye CTO-Crossing Catheter received FDA 510(k) clearance on 2020-09-10, under 510(k) number K201330.

Who is the listed applicant for Tigereye CTO-Crossing Catheter?

The FDA 510(k) record lists Avinger, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Tigereye CTO-Crossing Catheter?

The FDA product code for Tigereye CTO-Crossing Catheter is PDU.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Avinger, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 12 項裝置 →

相關器械(代碼:PDU)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑